Curative Biotechnology (Curative Biotechnology) Additional Paid-In Capital : $15.81 Mil(As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology Additional Paid-In Capital?

Curative Biotechnology's quarterly additional paid-in capital increased from Sep. 2022 ($11.92 Mil) to Dec. 2022 ($12.02 Mil) and increased from Dec. 2022 ($12.02 Mil) to Mar. 2023 ($15.81 Mil).

Curative Biotechnology's annual additional paid-in capital increased from Dec. 2020 ($3.58 Mil) to Dec. 2021 ($10.50 Mil) and increased from Dec. 2021 ($10.50 Mil) to Dec. 2022 ($12.02 Mil).

Curative Biotechnology Additional Paid-In Capital Historical Data

The historical data trend for Curative Biotechnology's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology Additional Paid-In Capital Chart

Curative Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

3.02

3.58

10.50

12.02

Curative Biotechnology Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Additional Paid-In Capital	Get a 7-Day Free Trial															11.59	11.65	11.92	12.02	15.81

Curative Biotechnology Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Curative Biotechnology Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Curative Biotechnology's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biotechnology (Curative Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431

Website

https://www.curativebiotech.com

Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.